Schizophrenia is a serious psychopathology marked by hallucinations, delusions, abnormal thinking, and emotional flatness. Symptoms: Positive symptoms include hallucinations (hearing or seeing things that are not there), delusions (false beliefs), and abnormal thinking, such as bouncing from one issue to another. Negative symptoms are those that indicate a loss of normal functioning, such as emotional flatness, lack of drive, and social isolation. Pharmacological treatments: The most often used therapy for schizophrenia is antipsychotic medication. These drugs operate by inhibiting dopamine receptors in the brain, reducing the excessive dopamine activity considered to contribute to schizophrenia's positive symptoms. Antipsychotic drugs are classified into two types: conventional antipsychotics (such as chlorpromazine and haloperidol) and atypical antipsychotics (such as clozapine, risperidone, and olanzapine) Neurotransmitters/hormones and receptor types that are specific: Dopamine is a neurotransmitter that is hypothesized to be involved with positive schizophrenia symptoms such as hallucinations and delusions. Antipsychotic drugs work by inhibiting dopamine receptors in the brain, which is likely to contribute to these symptoms. Glutamate is a neurotransmitter that is hypothesized to have a role in unfavorable symptoms of schizophrenia such as emotional flatness and lack of desire. Some atypical antipsychotic drugs may function by targeting the glutamate system in the brain, according to new study. Schizophrenia is a complicated condition with various origins, and it is believed to be impacted by both hereditary and environmental factors. According to twin studies, the heritability of schizophrenia is roughly 80%. Recent study has revealed numerous genes associated with the dopamine and glutamate neurotransmitter systems that may enhance the chance of developing schizophrenia. Neuroimaging and other data on brain differences and mechanisms: Individuals with schizophrenia have aberrant brain structure, such as lower brain volume and diminished gray matter in particular brain areas, such as the prefrontal cortex, temporal lobes, and hippocampus, according to structural brain imaging studies. Individuals with schizophrenia show aberrant brain activity in particular brain areas, such as the prefrontal cortex, temporal lobes, and hippocampus, which are important in cognitive functions such as attention, memory, and emotion, according to functional neuroimaging studies. According to research, patients with schizophrenia have aberrant connection between distinct brain areas, which may contribute to the disorder's symptoms. Schizophrenia is a complicated condition with symptoms such as hallucinations, delusions, disorganized thinking, and emotional flatness. Genetic and environmental factors are known to impact it, and research has found numerous genes that may raise the likelihood of having the illness. Antipsychotic medicine, which acts by inhibiting dopamine receptors in the brain, is the main therapy for schizophrenia. Brain imaging studies have shown that people with schizophrenia have aberrant brain structure and activity in certain brain areas, as well as faulty connection between other brain regions, which may contribute to the disorder's symptoms. 